Wedbush Reiterates Outperform on IDEAYA Biosciences, Maintains $52 Price Target

IDEAYA Biosciences -6.31%

IDEAYA Biosciences

IDYA

31.48

-6.31%

Wedbush analyst Robert Driscoll reiterates IDEAYA Biosciences (NASDAQ: IDYA) with a Outperform and maintains $52 price target.